,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,5.3138167182287e-07,0.0004367957342384
2,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,3.89134160352864e-05,0.0159934139905027
3,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.000161552008706572,0.0442652503856008
4,WP_COMPLEMENT_ACTIVATION,12,Up,0.000423640151220282,0.0731306930912878
5,WP_BENZENE_METABOLISM,3,Up,0.000444833899582042,0.0731306930912878
6,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.00139013334621802,0.190448268431869
7,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.00276136041046541,0.290969205705192
8,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.00325815334006943,0.290969205705192
9,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.00353661539600375,0.290969205705192
10,WP_FERROPTOSIS,49,Up,0.00353977135894394,0.290969205705192
11,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.00420437765350717,0.31261940647521
12,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.00456378695584248,0.31261940647521
13,WP_CHOLESTASIS,8,Up,0.00497184025395034,0.314373283749783
14,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.00630473888971048,0.37017824052443
15,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Up,0.00703389258346735,0.372129578442121
16,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.00733115124078846,0.372129578442121
17,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,28,Up,0.00769611050306091,0.372129578442121
18,WP_COMPLEMENT_SYSTEM,50,Up,0.00938583285994834,0.428619700604307
19,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.0111176066967057,0.480982773931162
20,WP_FOXA2_PATHWAY,9,Up,0.0128154993796575,0.518404024454004
21,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.0148547735208383,0.518404024454004
22,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.0148547735208383,0.518404024454004
23,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.015059202050576,0.518404024454004
24,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.0151358839256644,0.518404024454004
25,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Up,0.0159273235528522,0.523690398417781
26,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.01719565968795,0.534913461219051
27,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.0175701501860272,0.534913461219051
28,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Up,0.0182965428063032,0.537134220956473
29,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.0221000239012974,0.606628467314594
30,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.022578612475907,0.606628467314594
31,WP_COPPER_HOMEOSTASIS,40,Up,0.0228777159206234,0.606628467314594
32,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.0236791341357131,0.608257758111131
33,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,72,Up,0.0272990067485985,0.679993440828725
34,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.0301468146989049,0.691423274633042
35,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,19,Up,0.0310547644090918,0.691423274633042
36,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.0321961210647409,0.691423274633042
37,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Up,0.0327667792582545,0.691423274633042
38,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.034003110566751,0.691423274633042
39,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,53,Down,0.0349805104110507,0.691423274633042
40,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Down,0.0359973991139017,0.691423274633042
41,WP_IRON_METABOLISM_DISORDERS,10,Up,0.0361679124208465,0.691423274633042
42,WP_SMALL_LIGAND_GPCRS,7,Up,0.0362453356757757,0.691423274633042
43,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.0369740359080309,0.691423274633042
44,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.0391955823999845,0.691423274633042
45,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.0401542373772379,0.691423274633042
46,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.0415250832670149,0.691423274633042
47,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,10,Up,0.0417065173425648,0.691423274633042
48,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.0422212996090379,0.691423274633042
49,WP_VITAMIN_D_RECEPTOR_PATHWAY,81,Up,0.0427988295010957,0.691423274633042
50,WP_CCL18_SIGNALING,20,Up,0.0454700806313135,0.691423274633042
51,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.0463385050178911,0.691423274633042
52,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Up,0.0481882247974701,0.691423274633042
53,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.0488249514220671,0.691423274633042
54,WP_PURINE_METABOLISM,10,Down,0.0492363962225643,0.691423274633042
55,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.049717611451712,0.691423274633042
56,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.049863293630736,0.691423274633042
57,WP_SPHINGOLIPID_PATHWAY,20,Down,0.0500919583025995,0.691423274633042
58,WP_GPCRS_CLASS_B_SECRETINLIKE,3,Down,0.0503278761961711,0.691423274633042
59,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.0518681343235855,0.691423274633042
60,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.0523792359059124,0.691423274633042
61,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.0526010221098258,0.691423274633042
62,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.0537023707558466,0.691423274633042
63,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.0567897112194624,0.691423274633042
64,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.0575156132688834,0.691423274633042
65,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.0576445244677362,0.691423274633042
66,WP_RETINOBLASTOMA_GENE_IN_CANCER,65,Down,0.0579371642729569,0.691423274633042
67,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.0583502923765682,0.691423274633042
68,WP_HUNGER_AND_SATIETY,2,Up,0.058572738884573,0.691423274633042
69,WP_OSTEOBLAST_SIGNALING,3,Down,0.0601556503987969,0.691423274633042
70,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Up,0.0604234482837443,0.691423274633042
71,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.0610930664941317,0.691423274633042
72,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.061126094377356,0.691423274633042
73,WP_KALLMANN_SYNDROME,10,Up,0.0614037701316449,0.691423274633042
74,WP_SPINA_BIFIDA,10,Down,0.06484572738312,0.70073234849648
75,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.065189898386711,0.70073234849648
76,WP_OSTEOPONTIN_SIGNALING,11,Down,0.0654677043670814,0.70073234849648
77,WP_PYRIMIDINE_METABOLISM,71,Down,0.0658327423398661,0.70073234849648
78,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.0664928505872573,0.70073234849648
79,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Up,0.068427547562476,0.711992963245004
80,WP_BENZOAPYRENE_METABOLISM,5,Up,0.0705377000171552,0.714931697588817
81,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.0710439961542051,0.714931697588817
82,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,35,Up,0.071543663475911,0.714931697588817
83,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.0725360388789645,0.714931697588817
84,WP_MEVALONATE_PATHWAY,7,Up,0.0738868693472925,0.714931697588817
85,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.0740558018838028,0.714931697588817
86,WP_PPARALPHA_PATHWAY,15,Up,0.0747982068036962,0.714931697588817
87,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Down,0.076291936809661,0.72082726502921
88,WP_PURINERGIC_SIGNALING,14,Up,0.0783505912792477,0.726917066494091
89,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.0795464785671829,0.726917066494091
90,WP_TAR_SYNDROME,43,Down,0.081320123721074,0.726917066494091
91,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,7,Up,0.0815584619315262,0.726917066494091
92,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,7,Up,0.0815584619315262,0.726917066494091
93,WP_AUTOPHAGY,27,Down,0.0822424418296234,0.726917066494091
94,WP_OREXIN_RECEPTOR_PATHWAY,114,Down,0.0843633253206085,0.737730355463193
95,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.0867681745300426,0.747617975160698
96,WP_TRYPTOPHAN_METABOLISM,17,Up,0.0879737649906631,0.747617975160698
97,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,10,Up,0.0885005576260837,0.747617975160698
98,WP_ZINC_HOMEOSTASIS,23,Up,0.0905180391607069,0.747617975160698
99,WP_NRF2ARE_REGULATION,20,Up,0.0908169365341842,0.747617975160698
100,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Up,0.090951091868698,0.747617975160698
101,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.0930359349406015,0.757183549714598
102,WP_OSTEOCLAST_SIGNALING,9,Down,0.0955121019456807,0.762052372029565
103,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,18,Up,0.0974723612138559,0.762052372029565
104,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.097552166325772,0.762052372029565
105,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.0998911884826221,0.762052372029565
106,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Up,0.10240280326742,0.762052372029565
107,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.103301117456733,0.762052372029565
108,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.103876502512278,0.762052372029565
109,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.104033079907667,0.762052372029565
110,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.104511175169766,0.762052372029565
111,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.104779559289951,0.762052372029565
112,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,10,Up,0.105579706163663,0.762052372029565
113,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.105615226881562,0.762052372029565
114,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,15,Up,0.105900763140413,0.762052372029565
115,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.106613166403163,0.762052372029565
116,WP_ECTODERM_DIFFERENTIATION,75,Up,0.117495599358936,0.832145685951263
117,WP_GPR40_PATHWAY,8,Down,0.121091881183337,0.832145685951263
118,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,40,Up,0.121220576488097,0.832145685951263
119,WP_ALSTROM_SYNDROME,27,Down,0.124934948367224,0.832145685951263
120,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.125684612779382,0.832145685951263
121,WP_IL1_SIGNALING,52,Down,0.125976156617213,0.832145685951263
122,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.127779854014745,0.832145685951263
123,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.127900930977307,0.832145685951263
124,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.129682428908822,0.832145685951263
125,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.130860666385404,0.832145685951263
126,WP_G_PROTEIN_SIGNALING,59,Up,0.131024043462963,0.832145685951263
127,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Up,0.131242025146023,0.832145685951263
128,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,22,Down,0.131772728707934,0.832145685951263
129,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.132245918876951,0.832145685951263
130,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.13226569911548,0.832145685951263
131,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.133347708518698,0.832145685951263
132,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.133783518870818,0.832145685951263
133,WP_KININKALLIKREIN_PATHWAY,2,Up,0.135777011732371,0.832145685951263
134,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.137070071763624,0.832145685951263
135,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.138552140918944,0.832145685951263
136,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.139558287900167,0.832145685951263
137,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.142538899496332,0.832145685951263
138,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.142650116816418,0.832145685951263
139,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.14299941038225,0.832145685951263
140,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.143212781882856,0.832145685951263
141,WP_STEROID_BIOSYNTHESIS,2,Down,0.143706491528893,0.832145685951263
142,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,32,Down,0.144009968804724,0.832145685951263
143,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,41,Up,0.144765003760378,0.832145685951263
144,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Up,0.14627979952866,0.835013855642769
145,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,87,Up,0.148222718057326,0.840269477538772
146,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.150881733039261,0.848065264804299
147,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.151661306479601,0.848065264804299
148,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.155694926226354,0.851113160945475
149,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.155989391059397,0.851113160945475
150,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.156344493113506,0.851113160945475
151,WP_MELATONIN_METABOLISM_AND_EFFECTS,18,Up,0.156906670434248,0.851113160945475
152,WP_PROTEOGLYCAN_BIOSYNTHESIS,14,Up,0.157383455551961,0.851113160945475
153,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.160182082026115,0.851297738247308
154,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.160297271061931,0.851297738247308
155,WP_CREATINE_PATHWAY,1,Down,0.160524512686536,0.851297738247308
156,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Up,0.162459023584485,0.851934558738003
157,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,12,Down,0.162717427885482,0.851934558738003
158,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.164502862009263,0.855831345389964
159,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.167131697253875,0.859920394688697
160,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,14,Up,0.168542553294621,0.859920394688697
161,WP_SERINE_METABOLISM,5,Down,0.169401992991066,0.859920394688697
162,WP_ONECARBON_METABOLISM,22,Down,0.170410359210381,0.859920394688697
163,WP_MRNA_PROCESSING,124,Down,0.171468096832388,0.859920394688697
164,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.171600134856623,0.859920394688697
165,WP_DISORDERS_IN_KETOLYSIS,3,Up,0.17261175805795,0.859920394688697
166,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Up,0.17427626303626,0.860277906878258
167,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.175161105210883,0.860277906878258
168,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.175823221843731,0.860277906878258
169,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.17803428907005,0.860998573231341
170,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.178447096022379,0.860998573231341
171,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,3,Up,0.179655196841153,0.860998573231341
172,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.180160285396339,0.860998573231341
173,WP_PPAR_SIGNALING,36,Up,0.183741650913781,0.871905926244043
174,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.186675311028198,0.871905926244043
175,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.187479690271478,0.871905926244043
176,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.188115968347797,0.871905926244043
177,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Up,0.189525034797362,0.871905926244043
178,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.189795132659254,0.871905926244043
179,WP_GLUCURONIDATION,7,Up,0.191667426387765,0.871905926244043
180,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Up,0.192098815641346,0.871905926244043
181,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Up,0.193532983768252,0.871905926244043
182,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Down,0.196974131626276,0.871905926244043
183,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.197308417930239,0.871905926244043
184,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.198656309731426,0.871905926244043
185,WP_B_CELL_RECEPTOR_SIGNALING,83,Down,0.200686044295735,0.871905926244043
186,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.201286290166451,0.871905926244043
187,WP_PROLACTIN_SIGNALING,69,Down,0.204359229071731,0.871905926244043
188,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.204655475379479,0.871905926244043
189,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,68,Down,0.204915217436395,0.871905926244043
190,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.205180725876079,0.871905926244043
191,WP_UROTENSINIIMEDIATED_SIGNALING,48,Up,0.205371141150774,0.871905926244043
192,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.205510911309552,0.871905926244043
193,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,14,Down,0.206660866647208,0.871905926244043
194,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.20724262413267,0.871905926244043
195,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,16,Up,0.208810626531823,0.871905926244043
196,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.208828477041395,0.871905926244043
197,WP_IDO_METABOLIC_PATHWAY,6,Down,0.208960422712988,0.871905926244043
198,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.216395049237679,0.873632920608542
199,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.217769532986462,0.873632920608542
200,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.219644008416085,0.873632920608542
201,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.220345105063889,0.873632920608542
202,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Down,0.221001759741474,0.873632920608542
203,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.222149678776205,0.873632920608542
204,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.223130436295308,0.873632920608542
205,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.22360129044157,0.873632920608542
206,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.225014576020944,0.873632920608542
207,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Down,0.226075450780823,0.873632920608542
208,WP_PROTEASOME_DEGRADATION,57,Down,0.226138054966391,0.873632920608542
209,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Up,0.226560705964516,0.873632920608542
210,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.226580266569696,0.873632920608542
211,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,44,Down,0.226609930050695,0.873632920608542
212,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.227313126478729,0.873632920608542
213,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.227425279669219,0.873632920608542
214,WP_TROP2_REGULATORY_SIGNALING,41,Up,0.227855046367871,0.873632920608542
215,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.228882423169644,0.873632920608542
216,WP_CHOLESTEROL_METABOLISM,48,Up,0.232429797901657,0.873632920608542
217,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,40,Up,0.2345317318845,0.873632920608542
218,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,37,Up,0.234850130722693,0.873632920608542
219,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.235102008549027,0.873632920608542
220,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.235307890017336,0.873632920608542
221,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.236009074481415,0.873632920608542
222,WP_NOTCH_SIGNALING_WP268,34,Up,0.236063902605254,0.873632920608542
223,WP_ATR_SIGNALING,10,Down,0.237007471162658,0.873632920608542
224,WP_WNT_SIGNALING_WP363,36,Up,0.241351420989491,0.883263951405204
225,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.241847594733068,0.883263951405204
226,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.243300711725727,0.883263951405204
227,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.244307035714169,0.883263951405204
228,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.244992920827721,0.883263951405204
229,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.251211347099659,0.898368731786725
230,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.251368379940325,0.898368731786725
231,WP_DOPAMINE_METABOLISM,7,Up,0.252822835257159,0.899655283902098
232,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.254836966687166,0.899724760778585
233,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,10,Down,0.255206535845266,0.899724760778585
234,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.256126026790984,0.899724760778585
235,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.257261736579138,0.899868712630006
236,WP_PARKINSONS_DISEASE_PATHWAY,25,Down,0.258758020794014,0.901267343613048
237,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.260410441963528,0.902410590072456
238,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.261557390921552,0.902410590072456
239,WP_LIPID_PARTICLES_COMPOSITION,4,Up,0.263419442472651,0.902410590072456
240,WP_NAD_METABOLISM,12,Down,0.265474299593572,0.902410590072456
241,WP_RAC1PAK1P38MMP2_PATHWAY,50,Up,0.265941310059104,0.902410590072456
242,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.26720345533742,0.902410590072456
243,WP_CAMKK2_PATHWAY,29,Up,0.267219749355234,0.902410590072456
244,WP_METHYLATION_PATHWAYS,5,Up,0.269153351671064,0.902410590072456
245,WP_VEGFAVEGFR2_SIGNALING,331,Up,0.272272247663254,0.902410590072456
246,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Up,0.2778792190739,0.902410590072456
247,WP_DNA_MISMATCH_REPAIR,21,Down,0.279817881561853,0.902410590072456
248,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Up,0.279997228626791,0.902410590072456
249,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Down,0.281394481730661,0.902410590072456
250,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.282221506532555,0.902410590072456
251,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.283136925773102,0.902410590072456
252,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.283180276190071,0.902410590072456
253,WP_OPIOID_RECEPTOR_PATHWAYS,24,Down,0.283234855153891,0.902410590072456
254,WP_INSULIN_SIGNALING,125,Down,0.283435748907386,0.902410590072456
255,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,133,Up,0.283522285931497,0.902410590072456
256,WP_PEPTIDE_GPCRS,11,Up,0.284141805786277,0.902410590072456
257,WP_MACROPHAGE_MARKERS,8,Down,0.284684687025985,0.902410590072456
258,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.285218175281074,0.902410590072456
259,WP_SMALL_CELL_LUNG_CANCER,68,Down,0.285580945113284,0.902410590072456
260,WP_ANDROGEN_RECEPTOR_SIGNALING,76,Up,0.286581173754703,0.902410590072456
261,WP_DRAVET_SYNDROME,11,Down,0.287208949363592,0.902410590072456
262,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.287629652796817,0.902410590072456
263,WP_NEUROINFLAMMATION,10,Down,0.289439778027665,0.904636872770877
264,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,79,Down,0.291585788086715,0.907892112906361
265,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.297453184279995,0.922666103691155
266,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.301522815577535,0.931773512799752
267,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.303732170032694,0.932125128432363
268,WP_APOPTOSIS,71,Down,0.30390454308987,0.932125128432363
269,WP_TAMOXIFEN_METABOLISM,2,Up,0.305545100497518,0.933673132375315
270,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,25,Up,0.307512768497995,0.93620553964945
271,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.309560967447141,0.938963524876568
272,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.312142599606376,0.9429331685975
273,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,9,Down,0.314116398757355,0.9429331685975
274,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.314311056199167,0.9429331685975
275,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.318148300035736,0.949754826287983
276,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Down,0.318895781089396,0.949754826287983
277,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.321789367882372,0.953191241426504
278,WP_MONOAMINE_GPCRS,3,Up,0.323538432427979,0.953191241426504
279,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.324824181423529,0.953191241426504
280,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.325540875979267,0.953191241426504
281,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.326072211264934,0.953191241426504
282,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.327007214212012,0.953191241426504
283,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Down,0.330031315388391,0.958606859538013
284,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.331498381040018,0.959477708503152
285,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.333862268014357,0.961338588360147
286,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Up,0.334480336096109,0.961338588360147
287,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.335875133756793,0.961983832571722
288,WP_SYNAPTIC_VESICLE_PATHWAY,21,Down,0.339585680422084,0.965724729728058
289,WP_GALANIN_RECEPTOR_PATHWAY,11,Down,0.340254850384615,0.965724729728058
290,WP_IRINOTECAN_PATHWAY,5,Up,0.341554704671731,0.965724729728058
291,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Up,0.342460333314625,0.965724729728058
292,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,12,Up,0.343609928380871,0.965724729728058
293,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.344267336619188,0.965724729728058
294,WP_ENDODERM_DIFFERENTIATION,80,Up,0.346853613304517,0.965724729728058
295,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Up,0.349821505629422,0.965724729728058
296,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,59,Down,0.350604813469445,0.965724729728058
297,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,19,Up,0.351048165467761,0.965724729728058
298,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.351598379246874,0.965724729728058
299,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.352540107742582,0.965724729728058
300,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Down,0.353334491108493,0.965724729728058
301,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.354511931951795,0.965724729728058
302,WP_ALLOGRAFT_REJECTION,50,Up,0.3548039761288,0.965724729728058
303,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.356878485487439,0.967927691868506
304,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,46,Up,0.358553369591072,0.967927691868506
305,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Up,0.359145919732232,0.967927691868506
306,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,62,Up,0.361498386409731,0.971083900747707
307,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.363275234197696,0.972678314366469
308,WP_BLADDER_CANCER,28,Down,0.36671902455991,0.978711162948851
309,WP_PTF1A_RELATED_REGULATORY_PATHWAY,5,Up,0.369900769464079,0.981814706918446
310,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.370270753217419,0.981814706918446
311,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.376286491135426,0.99040814635812
312,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.3765836139146,0.99040814635812
313,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Up,0.380751032884866,0.99040814635812
314,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.382382520096023,0.99040814635812
315,WP_PHOSPHOINOSITIDES_METABOLISM,38,Down,0.382455536371294,0.99040814635812
316,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.385109011244435,0.99040814635812
317,WP_ENDOTHELIN_PATHWAYS,10,Up,0.386699573539818,0.99040814635812
318,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.386714069048115,0.99040814635812
319,WP_GLUTATHIONE_METABOLISM,10,Up,0.389464586039036,0.99040814635812
320,WP_ONCOSTATIN_M_SIGNALING,52,Down,0.391216344601576,0.99040814635812
321,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.393867700061515,0.99040814635812
322,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Up,0.39988581921209,0.99040814635812
323,WP_IL5_SIGNALING,37,Up,0.400479404324797,0.99040814635812
324,WP_HIPPOYAP_SIGNALING,16,Down,0.401814213211433,0.99040814635812
325,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.403079420583846,0.99040814635812
326,WP_MONOAMINE_TRANSPORT,11,Down,0.405051022340462,0.99040814635812
327,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.40652634114865,0.99040814635812
328,WP_JOUBERT_SYNDROME,70,Up,0.406933804952274,0.99040814635812
329,WP_IL19_SIGNALING,20,Up,0.411708699026478,0.99040814635812
330,WP_WNT_SIGNALING_AND_PLURIPOTENCY,56,Up,0.415969767331395,0.99040814635812
331,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.416504005730545,0.99040814635812
332,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Up,0.417305812825666,0.99040814635812
333,WP_TCELL_ACTIVATION_SARSCOV2,61,Up,0.42063019207733,0.99040814635812
334,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.422010788530629,0.99040814635812
335,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.422696741935543,0.99040814635812
336,WP_SILDENAFIL_TREATMENT,11,Down,0.423722562393061,0.99040814635812
337,WP_KIT_RECEPTOR_SIGNALING,49,Down,0.425181576558817,0.99040814635812
338,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.428060666470206,0.99040814635812
339,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.432292286061592,0.99040814635812
340,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.432538893925315,0.99040814635812
341,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.434656088842532,0.99040814635812
342,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.434756902800032,0.99040814635812
343,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.435339600092279,0.99040814635812
344,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.435623768835403,0.99040814635812
345,WP_FOLATE_METABOLISM,36,Down,0.43580746757134,0.99040814635812
346,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.436023341419265,0.99040814635812
347,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.436085322730224,0.99040814635812
348,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.436582390054999,0.99040814635812
349,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,31,Up,0.439313151953164,0.99040814635812
350,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.439400450837594,0.99040814635812
351,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.439920551607471,0.99040814635812
352,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.442287311770249,0.99040814635812
353,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,86,Up,0.442695479780264,0.99040814635812
354,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.44365510526864,0.99040814635812
355,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Down,0.443701478189064,0.99040814635812
356,WP_TCELL_RECEPTOR_SIGNALING,71,Down,0.444294902053357,0.99040814635812
357,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,67,Up,0.444350853626762,0.99040814635812
358,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.445007506082826,0.99040814635812
359,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.445431955100584,0.99040814635812
360,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.44644689480409,0.99040814635812
361,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.449832659568235,0.99040814635812
362,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.450799343839395,0.99040814635812
363,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Up,0.451156686772692,0.99040814635812
364,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.453515362803284,0.99040814635812
365,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.454173008794417,0.99040814635812
366,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.457753735586459,0.99040814635812
367,WP_CANCER_PATHWAYS,292,Up,0.46405448892703,0.99040814635812
368,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,14,Up,0.464831706711985,0.99040814635812
369,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.46578210691041,0.99040814635812
370,WP_ARYLAMINE_METABOLISM,1,Up,0.468305408629492,0.99040814635812
371,WP_GPCRS_CLASS_A_RHODOPSINLIKE,38,Up,0.46865391870833,0.99040814635812
372,WP_GPCRS_OTHER,11,Down,0.470532751140654,0.99040814635812
373,WP_NEURAL_CREST_DIFFERENTIATION,35,Up,0.47165280193937,0.99040814635812
374,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.472062961744183,0.99040814635812
375,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.472252872596779,0.99040814635812
376,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.472252872596779,0.99040814635812
377,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,64,Up,0.473235622072769,0.99040814635812
378,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.474374871156064,0.99040814635812
379,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.474430398338603,0.99040814635812
380,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,167,Down,0.474683583503952,0.99040814635812
381,WP_PDGFRBETA_PATHWAY,26,Up,0.474762299638276,0.99040814635812
382,WP_INTEGRATED_CANCER_PATHWAY,39,Up,0.476593278327024,0.99040814635812
383,WP_NEPHROGENESIS,4,Down,0.476815115300809,0.99040814635812
384,WP_OMEGA9_FATTY_ACID_SYNTHESIS,9,Up,0.477057648084947,0.99040814635812
385,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.477219206105044,0.99040814635812
386,WP_NPHP1_DELETION_SYNDROME,10,Up,0.477793013797235,0.99040814635812
387,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Up,0.48022697395792,0.99040814635812
388,WP_IL4_SIGNALING,50,Down,0.481407100522797,0.99040814635812
389,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Down,0.483973454196751,0.99040814635812
390,WP_ANGIOGENESIS,13,Down,0.484320424401147,0.99040814635812
391,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Up,0.484461564138229,0.99040814635812
392,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,47,Up,0.485409630690055,0.99040814635812
393,WP_GASTRIC_CANCER_NETWORK_1,15,Down,0.486070949479888,0.99040814635812
394,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.486560935944401,0.99040814635812
395,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.486844671428266,0.99040814635812
396,WP_LEPTIN_SIGNALING,69,Down,0.488180523113971,0.99040814635812
397,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,12,Up,0.489043009258391,0.99040814635812
398,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.489345942700071,0.99040814635812
399,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.489405498045039,0.99040814635812
400,WP_AMINO_ACID_METABOLISM,57,Up,0.489931500563363,0.99040814635812
401,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,19,Up,0.489943094064549,0.99040814635812
402,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.491187248402052,0.99040814635812
403,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,84,Down,0.491706501216902,0.99040814635812
404,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,80,Down,0.492193179391409,0.99040814635812
405,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,11,Down,0.496056888364349,0.99040814635812
406,WP_EICOSANOID_SYNTHESIS,13,Up,0.496184216291564,0.99040814635812
407,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Down,0.497187222595933,0.99040814635812
408,WP_TNFALPHA_SIGNALING,83,Up,0.497202545450336,0.99040814635812
409,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.497598926858622,0.99040814635812
410,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,38,Down,0.49953218414226,0.99040814635812
411,WP_TGFBETA_RECEPTOR_SIGNALING,34,Down,0.499752896284641,0.99040814635812
412,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.500432859049014,0.99040814635812
413,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Up,0.501376273733473,0.99040814635812
414,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.50182961760569,0.99040814635812
415,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.50316732362227,0.99040814635812
416,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.504409257176607,0.99040814635812
417,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Up,0.506372987935543,0.99040814635812
418,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Up,0.507930081995069,0.99040814635812
419,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Down,0.508648112096678,0.99040814635812
420,WP_VITAMIN_B12_DISORDERS,9,Up,0.509099208519479,0.99040814635812
421,WP_TRANSLATION_FACTORS,49,Down,0.509169583300868,0.99040814635812
422,WP_NRF2_PATHWAY,68,Up,0.510393789131495,0.99040814635812
423,WP_IL6_SIGNALING,39,Up,0.513348869470013,0.99040814635812
424,WP_BLOOD_CLOTTING_CASCADE,5,Down,0.514478603592508,0.99040814635812
425,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.516078855631245,0.99040814635812
426,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.516695287702892,0.99040814635812
427,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Down,0.517279168134354,0.99040814635812
428,WP_WNT_SIGNALING_WP428,57,Up,0.517683061200165,0.99040814635812
429,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.517912683516783,0.99040814635812
430,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Up,0.5180967188978,0.99040814635812
431,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,60,Down,0.520439136911299,0.991355051649776
432,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.521004114735649,0.991355051649776
433,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.524831618732037,0.99496392085216
434,WP_ID_SIGNALING,11,Up,0.527052720501636,0.99496392085216
435,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,28,Down,0.527911428347366,0.99496392085216
436,WP_IL7_SIGNALING,23,Down,0.530868573856415,0.99496392085216
437,WP_ATM_SIGNALING,33,Down,0.532349573713094,0.99496392085216
438,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.533190781159217,0.99496392085216
439,WP_SPINAL_CORD_INJURY,63,Down,0.533498753762408,0.99496392085216
440,WP_OXIDATION_BY_CYTOCHROME_P450,14,Down,0.533743672624758,0.99496392085216
441,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,18,Down,0.537909763292598,0.99496392085216
442,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.540391463969991,0.99496392085216
443,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,112,Up,0.541808207912908,0.99496392085216
444,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,52,Down,0.542448231678294,0.99496392085216
445,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,13,Up,0.543852560578197,0.99496392085216
446,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.544446653463594,0.99496392085216
447,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,3,Down,0.548822853021302,0.99496392085216
448,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.550139118258044,0.99496392085216
449,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Up,0.552874807124635,0.99496392085216
450,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.553310923881617,0.99496392085216
451,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.554337590166699,0.99496392085216
452,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.555546190429493,0.99496392085216
453,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.556511446648748,0.99496392085216
454,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.559192489272795,0.99496392085216
455,WP_BURN_WOUND_HEALING,57,Up,0.561090301588123,0.99496392085216
456,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.561324567028552,0.99496392085216
457,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.561543876658614,0.99496392085216
458,WP_HEME_BIOSYNTHESIS,8,Down,0.561543876658614,0.99496392085216
459,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.563942615419359,0.99496392085216
460,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Down,0.564256522120891,0.99496392085216
461,WP_VITAMIN_B12_METABOLISM,23,Up,0.565315955972584,0.99496392085216
462,WP_CYTOSINE_METHYLATION,7,Down,0.565944740191928,0.99496392085216
463,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.566255328757509,0.99496392085216
464,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.567086219489132,0.99496392085216
465,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.568490962373778,0.99496392085216
466,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.570334273331936,0.99496392085216
467,WP_ACUTE_MYELOID_LEUKEMIA,54,Up,0.570529539742681,0.99496392085216
468,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.571475759236707,0.99496392085216
469,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.572539899872116,0.99496392085216
470,WP_ERBB_SIGNALING,66,Down,0.574384621449769,0.99496392085216
471,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,64,Down,0.581514875894345,0.99496392085216
472,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.581682700046964,0.99496392085216
473,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,36,Down,0.585848420166044,0.99496392085216
474,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,51,Up,0.587655901805778,0.99496392085216
475,WP_16P112_DISTAL_DELETION_SYNDROME,20,Up,0.594238593315165,0.99496392085216
476,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Down,0.595009359509763,0.99496392085216
477,WP_CELL_CYCLE,92,Up,0.59517780184039,0.99496392085216
478,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.596594048561976,0.99496392085216
479,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Up,0.599353361453802,0.99496392085216
480,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Down,0.600253350860897,0.99496392085216
481,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,27,Down,0.60243233143443,0.99496392085216
482,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,3,Up,0.602818488933327,0.99496392085216
483,WP_HISTONE_MODIFICATIONS,35,Up,0.606037778203444,0.99496392085216
484,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,41,Up,0.606336432440647,0.99496392085216
485,WP_CILIOPATHIES,120,Up,0.609739708269577,0.99496392085216
486,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.609786473784602,0.99496392085216
487,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.609786473784602,0.99496392085216
488,WP_HYPERTROPHY_MODEL,13,Down,0.610492227128434,0.99496392085216
489,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.611018012187392,0.99496392085216
490,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.611018012187392,0.99496392085216
491,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Up,0.611502096007489,0.99496392085216
492,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.612857132997556,0.99496392085216
493,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.614692584650321,0.99496392085216
494,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.615232570660641,0.99496392085216
495,WP_NRXN1_DELETION_SYNDROME,2,Up,0.616171840530127,0.99496392085216
496,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.618680183106854,0.99496392085216
497,WP_AGERAGE_PATHWAY,53,Up,0.622329774971107,0.99496392085216
498,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.625372837236044,0.99496392085216
499,WP_MATRIX_METALLOPROTEINASES,7,Up,0.626241087975918,0.99496392085216
500,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Up,0.6263277546809,0.99496392085216
501,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.626696050583251,0.99496392085216
502,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.626743537265054,0.99496392085216
503,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.628161160002035,0.99496392085216
504,WP_SEROTONIN_AND_ANXIETY,5,Down,0.630002441974127,0.99496392085216
505,WP_ASPIRIN_AND_MIRNAS,8,Up,0.630730559858598,0.99496392085216
506,WP_GASTRIC_CANCER_NETWORK_2,24,Down,0.630936145719325,0.99496392085216
507,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.631045987825985,0.99496392085216
508,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.631824602619277,0.99496392085216
509,WP_AXON_GUIDANCE,35,Up,0.634174314309537,0.99496392085216
510,WP_CILIARY_LANDSCAPE,182,Down,0.634517854815769,0.99496392085216
511,WP_RETT_SYNDROME,29,Down,0.634835997767524,0.99496392085216
512,WP_PREIMPLANTATION_EMBRYO,21,Up,0.635328927047709,0.99496392085216
513,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.636052930607723,0.99496392085216
514,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,58,Down,0.636345099774939,0.99496392085216
515,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.639637032147233,0.99496392085216
516,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.640249012154441,0.99496392085216
517,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,266,Up,0.64190749807571,0.99496392085216
518,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.643565554598334,0.99496392085216
519,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,82,Down,0.643607143826555,0.99496392085216
520,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.646794195575682,0.99496392085216
521,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Up,0.646825769543516,0.99496392085216
522,WP_OVARIAN_INFERTILITY,21,Down,0.647415752053546,0.99496392085216
523,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Up,0.647476189472231,0.99496392085216
524,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.648405107446767,0.99496392085216
525,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.648819133088732,0.99496392085216
526,WP_CHEMOKINE_SIGNALING,106,Up,0.649499244427117,0.99496392085216
527,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.651165903183428,0.99496392085216
528,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.655529357544122,0.99496392085216
529,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.658109721941972,0.99496392085216
530,WP_LUNG_PATHOLOGY_OF_COVID19,14,Down,0.658570470914055,0.99496392085216
531,WP_RANKLRANK_SIGNALING,47,Down,0.659874594697467,0.99496392085216
532,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Down,0.661384702126312,0.99496392085216
533,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Down,0.661570363687728,0.99496392085216
534,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.662461624896313,0.99496392085216
535,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.662640793505541,0.99496392085216
536,WP_INTEGRINMEDIATED_CELL_ADHESION,69,Up,0.663509167699346,0.99496392085216
537,WP_TGFB_SMAD_SIGNALING,7,Up,0.664448555018461,0.99496392085216
538,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Up,0.665854084201158,0.99496392085216
539,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.666220070398045,0.99496392085216
540,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,27,Down,0.667270053650314,0.99496392085216
541,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.668206336572127,0.99496392085216
542,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Up,0.669331958545733,0.99496392085216
543,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,87,Down,0.67077372812272,0.99496392085216
544,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.672194037700381,0.99496392085216
545,WP_NEOVASCULARIZATION_PROCESSES,21,Down,0.672353952414769,0.99496392085216
546,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.673337050929411,0.99496392085216
547,WP_IL18_SIGNALING,184,Up,0.673892896581282,0.99496392085216
548,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.676399576926656,0.99496392085216
549,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.676451331956316,0.99496392085216
550,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.678050353252289,0.99496392085216
551,WP_TARGET_OF_RAPAMYCIN_SIGNALING,31,Down,0.679208383764368,0.99496392085216
552,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.680159632258053,0.99496392085216
553,WP_RAS_SIGNALING,113,Up,0.684939482326702,0.99496392085216
554,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Up,0.686320030764848,0.99496392085216
555,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.686979688304465,0.99496392085216
556,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.689384402143564,0.99496392085216
557,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.693786934441916,0.99496392085216
558,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.697951078003939,0.99496392085216
559,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.698334008268965,0.99496392085216
560,WP_TCA_CYCLE_IN_SENESCENCE,9,Up,0.699765681014385,0.99496392085216
561,WP_VITAMIN_D_METABOLISM,5,Down,0.70027486819758,0.99496392085216
562,WP_HIPPO_SIGNALING_REGULATION,42,Up,0.700798103306769,0.99496392085216
563,WP_VALPROIC_ACID_PATHWAY,8,Up,0.700818870469661,0.99496392085216
564,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Up,0.700879562105124,0.99496392085216
565,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.702111430128481,0.99496392085216
566,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Up,0.702279607541326,0.99496392085216
567,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.706243440219567,0.99496392085216
568,WP_KREBS_CYCLE_DISORDERS,11,Down,0.708823445374963,0.99496392085216
569,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.709880370879152,0.99496392085216
570,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Up,0.710458005663008,0.99496392085216
571,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Up,0.710545937373382,0.99496392085216
572,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.711512753539071,0.99496392085216
573,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,9,Up,0.711635589181344,0.99496392085216
574,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,51,Down,0.713361854695571,0.99496392085216
575,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.713639062626367,0.99496392085216
576,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.714661396718162,0.99496392085216
577,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.714837116235954,0.99496392085216
578,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Up,0.716623494974307,0.99496392085216
579,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.71835306536894,0.99496392085216
580,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.718797072490749,0.99496392085216
581,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.719666905405346,0.99496392085216
582,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.720537251245379,0.99496392085216
583,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.721531866459211,0.99496392085216
584,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,11,Down,0.721724120436879,0.99496392085216
585,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.723252939935202,0.99496392085216
586,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.724415451867552,0.99496392085216
587,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.725279134703342,0.99496392085216
588,WP_KLEEFSTRA_SYNDROME,25,Down,0.725402726306016,0.99496392085216
589,WP_BREAST_CANCER_PATHWAY,82,Up,0.727149796412152,0.99496392085216
590,WP_G1_TO_S_CELL_CYCLE_CONTROL,50,Down,0.728517004768937,0.99496392085216
591,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.729628713986457,0.99496392085216
592,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.730632127247195,0.99496392085216
593,WP_MAPK_CASCADE,30,Up,0.73110603730648,0.99496392085216
594,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Up,0.732370608679648,0.99496392085216
595,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.732713302919243,0.99496392085216
596,WP_DNA_DAMAGE_RESPONSE,57,Down,0.735390311500599,0.99496392085216
597,WP_PRION_DISEASE_PATHWAY,27,Up,0.737158309171936,0.99496392085216
598,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.737529275918193,0.99496392085216
599,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.738960816365366,0.99496392085216
600,WP_MIRNA_BIOGENESIS,6,Down,0.73944142054559,0.99496392085216
601,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,52,Up,0.743504242191906,0.99496392085216
602,WP_CORI_CYCLE,11,Down,0.745159318113747,0.99496392085216
603,WP_GASTRIN_SIGNALING,91,Down,0.745616596645444,0.99496392085216
604,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.746599164324625,0.99496392085216
605,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Up,0.748340450399908,0.99496392085216
606,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,29,Down,0.749549235808137,0.99496392085216
607,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,79,Up,0.752716457307578,0.99496392085216
608,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.752798886509113,0.99496392085216
609,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Down,0.752801590222599,0.99496392085216
610,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Up,0.753130722713453,0.99496392085216
611,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.753500157742243,0.99496392085216
612,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.75359043605794,0.99496392085216
613,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,16,Down,0.754589194999441,0.99496392085216
614,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Up,0.756836133708219,0.99496392085216
615,WP_MAPK_SIGNALING,160,Up,0.75866445234021,0.99496392085216
616,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Up,0.760197401541738,0.99496392085216
617,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Down,0.760378290594598,0.99496392085216
618,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,12,Up,0.761805086833508,0.99496392085216
619,WP_GLIOBLASTOMA_SIGNALING,64,Down,0.761887351166592,0.99496392085216
620,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,26,Up,0.764396306476146,0.99496392085216
621,WP_THERMOGENESIS,72,Up,0.764717459860759,0.99496392085216
622,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.765190105000497,0.99496392085216
623,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Up,0.765255825509901,0.99496392085216
624,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.767336845631092,0.99496392085216
625,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.767831988413411,0.99496392085216
626,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.768724170778668,0.99496392085216
627,WP_CIRCADIAN_RHYTHM_GENES,114,Down,0.769309988141579,0.99496392085216
628,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.77052316813862,0.99496392085216
629,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.77115188156044,0.99496392085216
630,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,48,Up,0.772177060697155,0.99496392085216
631,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.772611863167028,0.99496392085216
632,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,2,Up,0.772826182184586,0.99496392085216
633,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,3,Down,0.774299911502815,0.99496392085216
634,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.775551969515859,0.99496392085216
635,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Down,0.777697143362771,0.99496392085216
636,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,29,Up,0.777775422831848,0.99496392085216
637,WP_ADIPOGENESIS,82,Up,0.77968558083716,0.99496392085216
638,WP_TP53_NETWORK,16,Down,0.781365146327189,0.99496392085216
639,WP_GLYOXYLATE_METABOLISM,5,Down,0.781489589448506,0.99496392085216
640,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.782920785405361,0.99496392085216
641,WP_RETINOL_METABOLISM,6,Up,0.783746332018177,0.99496392085216
642,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.785115169128703,0.99496392085216
643,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,36,Down,0.785935862443685,0.99496392085216
644,WP_HEDGEHOG_SIGNALING_WP4249,24,Up,0.788616714048734,0.99496392085216
645,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.788880091903081,0.99496392085216
646,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Up,0.789931419415236,0.99496392085216
647,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.790331727543381,0.99496392085216
648,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,32,Down,0.793412115409151,0.99496392085216
649,WP_MTHFR_DEFICIENCY,18,Down,0.796250163663232,0.99496392085216
650,WP_NONSMALL_CELL_LUNG_CANCER,57,Down,0.796820269974524,0.99496392085216
651,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.800823833483778,0.99496392085216
652,WP_ESTROGEN_SIGNALING,21,Up,0.80177706446359,0.99496392085216
653,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.806077327997315,0.99496392085216
654,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Up,0.807781825926025,0.99496392085216
655,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,5,Up,0.808075444735839,0.99496392085216
656,WP_NEPHROTIC_SYNDROME,28,Up,0.80877935931173,0.99496392085216
657,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Down,0.808863106251282,0.99496392085216
658,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Down,0.809820267290664,0.99496392085216
659,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.810063062123388,0.99496392085216
660,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,62,Up,0.810385356203477,0.99496392085216
661,WP_BASE_EXCISION_REPAIR,29,Up,0.81078425857719,0.99496392085216
662,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.811866988266247,0.99496392085216
663,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.813027983121693,0.99496392085216
664,WP_IL11_SIGNALING,40,Down,0.81405804734165,0.99496392085216
665,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.820812800361349,0.99496392085216
666,WP_MALE_INFERTILITY,65,Down,0.821826341663834,0.99496392085216
667,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Up,0.822273063920785,0.99496392085216
668,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.822305469604413,0.99496392085216
669,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,55,Down,0.82422752889462,0.99496392085216
670,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.825788321061197,0.99496392085216
671,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.828622664361394,0.99496392085216
672,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Up,0.829930330243705,0.99496392085216
673,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,54,Down,0.830516109797429,0.99496392085216
674,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Up,0.831248603053232,0.99496392085216
675,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.831515652385524,0.99496392085216
676,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.832462425852423,0.99496392085216
677,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,8,Up,0.834504488073499,0.99496392085216
678,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.836135629598659,0.99496392085216
679,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.83856804945232,0.99496392085216
680,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,29,Up,0.839186909027623,0.99496392085216
681,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.840233741268595,0.99496392085216
682,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.841949990385639,0.99496392085216
683,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.847041432679551,0.99496392085216
684,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.849084987341594,0.99496392085216
685,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,13,Up,0.850105054999157,0.99496392085216
686,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.850753713503927,0.99496392085216
687,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Down,0.851433594571173,0.99496392085216
688,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.851871447423466,0.99496392085216
689,WP_NOTCH_SIGNALING_WP61,47,Up,0.853598143432,0.99496392085216
690,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.853853775179424,0.99496392085216
691,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Up,0.855379593426649,0.99496392085216
692,WP_PRIMARY_OVARIAN_INSUFFICIENCY,88,Up,0.856889701136463,0.99496392085216
693,WP_HEART_DEVELOPMENT,15,Down,0.857557470713949,0.99496392085216
694,WP_PROSTAGLANDIN_SIGNALING,21,Down,0.857734561929964,0.99496392085216
695,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.857851093691924,0.99496392085216
696,WP_TRANSSULFURATION_PATHWAY,8,Down,0.858583126997104,0.99496392085216
697,WP_G13_SIGNALING,29,Up,0.860471506962673,0.99496392085216
698,WP_LUNG_FIBROSIS,31,Down,0.864506142943112,0.99496392085216
699,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,25,Down,0.866565620309198,0.99496392085216
700,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Down,0.86723461552218,0.99496392085216
701,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.867518923326757,0.99496392085216
702,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,13,Up,0.8680620280031,0.99496392085216
703,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Up,0.869753452839719,0.99496392085216
704,WP_IL3_SIGNALING,46,Up,0.870263728913632,0.99496392085216
705,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,73,Up,0.871243342682175,0.99496392085216
706,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Down,0.8719241333006,0.99496392085216
707,WP_ESTROGEN_METABOLISM_WP5276,8,Down,0.874190487711467,0.99496392085216
708,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.875824039987859,0.99496392085216
709,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.876541660482476,0.99496392085216
710,WP_PDGF_PATHWAY,36,Down,0.876668370752723,0.99496392085216
711,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.878593970613309,0.99496392085216
712,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Down,0.878693220155022,0.99496392085216
713,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.87886329278688,0.99496392085216
714,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,85,Up,0.87896553665021,0.99496392085216
715,WP_UREA_CYCLE_AND_RELATED_DISEASES,2,Down,0.882461444064902,0.99496392085216
716,WP_ENERGY_METABOLISM,41,Down,0.887420022714846,0.99496392085216
717,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.88744541363239,0.99496392085216
718,WP_MESODERMAL_COMMITMENT_PATHWAY,72,Down,0.888078847378628,0.99496392085216
719,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.889312693341981,0.99496392085216
720,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.889725899924427,0.99496392085216
721,WP_PLEURAL_MESOTHELIOMA,242,Up,0.890172946471637,0.99496392085216
722,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.890373042173314,0.99496392085216
723,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.894187114719495,0.99496392085216
724,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Down,0.895553370695326,0.99496392085216
725,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,24,Up,0.896752634458732,0.99496392085216
726,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.896753272732311,0.99496392085216
727,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,4,Up,0.897624880133269,0.99496392085216
728,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.900118501622999,0.99496392085216
729,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.901168365404198,0.99496392085216
730,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.901262922399499,0.99496392085216
731,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.901417388900567,0.99496392085216
732,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,163,Down,0.902061214497741,0.99496392085216
733,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.902951556094412,0.99496392085216
734,WP_NUCLEOTIDE_GPCRS,6,Up,0.903611230916337,0.99496392085216
735,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.903879185069884,0.99496392085216
736,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,9,Down,0.907973339751453,0.99496392085216
737,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.90851042630778,0.99496392085216
738,WP_IL9_SIGNALING,15,Down,0.909680818918835,0.99496392085216
739,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.910291362406318,0.99496392085216
740,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.911135650912719,0.99496392085216
741,WP_ENDOMETRIAL_CANCER,48,Down,0.912804689704636,0.99496392085216
742,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.913584611874512,0.99496392085216
743,WP_EGFEGFR_SIGNALING,135,Down,0.915828627099235,0.99496392085216
744,WP_P38_MAPK_SIGNALING,31,Down,0.917314379513789,0.99496392085216
745,WP_IL17_SIGNALING,25,Down,0.918273592525786,0.99496392085216
746,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Down,0.91858765501303,0.99496392085216
747,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.920145678171061,0.99496392085216
748,WP_MICROTUBULE_CYTOSKELETON_REGULATION,34,Down,0.921907704334895,0.99496392085216
749,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,75,Down,0.921926085891347,0.99496392085216
750,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.922172843958218,0.99496392085216
751,WP_NUCLEAR_RECEPTORS,20,Down,0.922546569781236,0.99496392085216
752,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,24,Down,0.926595010162816,0.99496392085216
753,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,59,Down,0.926878191983681,0.99496392085216
754,WP_FOCAL_ADHESION,115,Up,0.92865355830669,0.99496392085216
755,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Up,0.93026217926094,0.99496392085216
756,WP_IL2_SIGNALING,37,Down,0.933736561040438,0.99496392085216
757,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.933741467238893,0.99496392085216
758,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.933841603807082,0.99496392085216
759,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,6,Up,0.934488252289596,0.99496392085216
760,WP_NETRINUNC5B_SIGNALING,35,Down,0.935356873295105,0.99496392085216
761,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.936744985566303,0.99496392085216
762,WP_PI3KAKT_SIGNALING,172,Down,0.936776947890188,0.99496392085216
763,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Down,0.937613481375014,0.99496392085216
764,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,72,Up,0.941246848397925,0.99496392085216
765,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.942732130990349,0.99496392085216
766,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,11,Down,0.943524402886835,0.99496392085216
767,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.944415303771107,0.99496392085216
768,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.945573582895669,0.99496392085216
769,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.945892582264027,0.99496392085216
770,WP_FRAGILE_X_SYNDROME,83,Down,0.946458613181355,0.99496392085216
771,WP_HEPATITIS_B_INFECTION,115,Down,0.946862855789363,0.99496392085216
772,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.947092781739139,0.99496392085216
773,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.948753799236633,0.99496392085216
774,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.949087961574022,0.99496392085216
775,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Down,0.94908974574021,0.99496392085216
776,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,34,Down,0.94915783574308,0.99496392085216
777,WP_MELANOMA,53,Down,0.949924838203676,0.99496392085216
778,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,10,Down,0.950268716212784,0.99496392085216
779,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.95335387554394,0.99496392085216
780,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.955252775062394,0.99496392085216
781,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.955530217781577,0.99496392085216
782,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.955858736517182,0.99496392085216
783,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.956193099416217,0.99496392085216
784,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Up,0.956212223545229,0.99496392085216
785,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.9562401987382,0.99496392085216
786,WP_BDNFTRKB_SIGNALING,26,Up,0.959013710586241,0.99496392085216
787,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Up,0.96006908377508,0.99496392085216
788,WP_APOPTOSIS_MODULATION_AND_SIGNALING,76,Down,0.960137389135614,0.99496392085216
789,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Up,0.960843318944772,0.99496392085216
790,WP_ALZHEIMERS_DISEASE,181,Up,0.963066024622347,0.99496392085216
791,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,181,Up,0.963066024622347,0.99496392085216
792,WP_ACUTE_VIRAL_MYOCARDITIS,63,Up,0.963498294544117,0.99496392085216
793,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,122,Up,0.965511383948454,0.99496392085216
794,WP_IL26_SIGNALING,31,Up,0.969340050132704,0.99496392085216
795,WP_MEASLES_VIRUS_INFECTION,100,Up,0.970868904849043,0.99496392085216
796,WP_FOXP3_IN_COVID19,9,Up,0.970998672226862,0.99496392085216
797,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Down,0.971043929674914,0.99496392085216
798,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.97283650491786,0.99496392085216
799,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.974314884585428,0.99496392085216
800,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Down,0.974968237906274,0.99496392085216
801,WP_BARDETBIEDL_SYNDROME,64,Up,0.975058728851291,0.99496392085216
802,WP_CELLULAR_PROTEOSTASIS,6,Up,0.976086719440235,0.99496392085216
803,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.976758838005476,0.99496392085216
804,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,2,Down,0.97679701108308,0.99496392085216
805,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.97928049306147,0.99496392085216
806,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.981172702847693,0.99496392085216
807,WP_NUCLEAR_RECEPTORS_METAPATHWAY,173,Down,0.98123516372944,0.99496392085216
808,WP_AEROBIC_GLYCOLYSIS,9,Up,0.981769385427479,0.99496392085216
809,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,9,Up,0.981769385427479,0.99496392085216
810,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.98329101916222,0.99496392085216
811,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.98524771770311,0.99496392085216
812,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Down,0.985570433327542,0.99496392085216
813,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,8,Down,0.985954981027864,0.99496392085216
814,WP_SLEEP_REGULATION,10,Up,0.98627450442848,0.99496392085216
815,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.987470959585649,0.99496392085216
816,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.987701410480976,0.99496392085216
817,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.992640941178561,0.997200008056111
818,WP_METABOLIC_EPILEPTIC_DISORDERS,54,Up,0.992884633774446,0.997200008056111
819,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,27,Up,0.993560591968315,0.997200008056111
820,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,58,Down,0.995669506506353,0.998097968717344
821,WP_DNA_REPLICATION,34,Down,0.997207231774844,0.998421856904899
822,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.998566781516626,0.998566781516626
